Product Information
GNP ANTIBACTRL-URINARY PAIN TB is a generic product labeled by AmerisourceBergen, priced at $0.1759 per EA under NDC 46122062262. Its NADAC has been published 163 times since Aug 23, 2023.
Strength
162; 162.5 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122062262
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHENAMINE; SODIUM SALICYLATEApproval Type
Unapproved
On Market Since
11/23/2019
Price Statistics
The NADAC for GNP ANTIBACTRL-URINARY PAIN TB has been published 163 times since Aug 23, 2023, and over the history we have for it it has risen 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1759 per EA |
|---|---|
| All-time high | $0.1796 (Jul 15, 2026) |
| All-time low | $0.1027 (Jul 17, 2024) |
| 52-week high | $0.1796 |
| 52-week low | $0.1663 |
| Median price | $0.1660 |
| Average price | $0.1569 |
| Largest weekly change | -19.9% (Jun 19, 2024) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METHENAMINE, SODIUM SALICYLATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHENAMINE, SODIUM SALICYLATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP ANTIBACTRL-URINARY PAIN TB?
The current National Average Drug Acquisition Cost (NADAC) for GNP ANTIBACTRL-URINARY PAIN TB, manufactured by AmerisourceBergen, is $0.1759 per EA (NDC 46122062262), effective Sep 30, 2026.
How has the price of GNP ANTIBACTRL-URINARY PAIN TB changed over time?
Over the history we have for it, the NADAC for GNP ANTIBACTRL-URINARY PAIN TB has risen 12.6%. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for GNP ANTIBACTRL-URINARY PAIN TB?
Since Aug 23, 2023, the NADAC for GNP ANTIBACTRL-URINARY PAIN TB has ranged from a low of $0.1027 (Jul 17, 2024) to a high of $0.1796 (Jul 15, 2026), with a median of $0.1660 per EA.
Are there cheaper alternatives to GNP ANTIBACTRL-URINARY PAIN TB?
No other NADAC-published product currently shares the active ingredient and strength of GNP ANTIBACTRL-URINARY PAIN TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP ANTIBACTRL-URINARY PAIN TB?
GNP ANTIBACTRL-URINARY PAIN TB (NDC 46122062262) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.